These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10912950

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
    Hall IH, Lee KH.
    Anticancer Res; 1991; 11(1):337-42. PubMed ID: 2018369
    [Abstract] [Full Text] [Related]

  • 23. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
    Newell SW, Perchellet EM, Ladesich JB, Freeman JA, Chen Y, Liu L, Hua DH, Kraft SL, Basaraba RJ, Perchellet JP.
    Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
    [Abstract] [Full Text] [Related]

  • 24. Isolation and characterization of an L1210 cell line retaining the sodium-dependent carrier cif as its sole nucleoside transport activity.
    Crawford CR, Ng CY, Belt JA.
    J Biol Chem; 1990 Aug 15; 265(23):13730-4. PubMed ID: 1974252
    [Abstract] [Full Text] [Related]

  • 25. Effect of derivatives of chrysophanol, a new type of potential antitumor agents of anthraquinone family, on growth and cell cycle of L1210 leukemic cells.
    Darzynkiewicz Z, Carter SP, Kapuscinski J, Watanabe KA.
    Cancer Lett; 1989 Aug 15; 46(3):181-7. PubMed ID: 2766258
    [Abstract] [Full Text] [Related]

  • 26. The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
    Jackson RC, Fry DW, Boritzki TJ, Roberts BJ, Hook KE, Leopold WR.
    Adv Enzyme Regul; 1985 Aug 15; 23():193-215. PubMed ID: 3840949
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
    Sood A, Spielvogel BF, Powell WJ, Bastow KF, Miller MC, Hall IH.
    Anticancer Res; 1994 Aug 15; 14(4A):1483-8. PubMed ID: 7979174
    [Abstract] [Full Text] [Related]

  • 28. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
    Bowden GT, Roberts R, Alberts DS, Peng YM, Garcia D.
    Cancer Res; 1985 Oct 15; 45(10):4915-20. PubMed ID: 4027978
    [Abstract] [Full Text] [Related]

  • 29. 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells.
    Cory JG, Downes DL, Ng CY, Belt JA.
    Oncol Res; 1992 Oct 15; 4(4-5):175-9. PubMed ID: 1504377
    [Abstract] [Full Text] [Related]

  • 30. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
    Parekh H, Chavan S, Chitnis M.
    Anticancer Drugs; 1991 Apr 15; 2(2):159-68. PubMed ID: 1683589
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N, Grabowski D, Ford J, Ganapathi R.
    Br J Cancer; 1993 Jun 15; 67(6):1203-8. PubMed ID: 8099806
    [Abstract] [Full Text] [Related]

  • 40. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
    Ganapathi R, Grabowski D.
    Biochem Pharmacol; 1988 Jan 15; 37(2):185-93. PubMed ID: 3342075
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.